3. Results
3.1. Baseline characteristics of the patients
Baseline characteristics of the patients by disease severity are summarized in Table 2. Of the data set consisting of 223 patients, 113 were male (50.7%), and 110 were female (49.3%). There were 41 patients (18.4%) with mild disease, 137 (61.4%) with moderate, 32 (14.3%) with severe, and 13 (5.8%) with critical. The average age of all patients was 50.09 ± 16.46 years; the mild ones were 36.17 ± 14.28 years, the moderate ones were 50.28 ± 14.88 years, the severe ones were 62.75 ± 13.63 years, and the critical ones were 60.85 ± 11.19 years, respectively.
Approximately 98.7% of the patients used Hydroxychloroquine, 63.7% Oseltamivir, 19.7% Azithromycin, 0.9% Lopinavir/Ritonavir, and 13.5% Favipiravir. About 50.7% of the patients had a fever, 54.3% had a cough, 71.3% had fatigue, 37.7% had dyspnea, and 50.7% had Myalgia/Arthralgia. The proportion of patients with headache is 26.5, the proportion of those with frontal type headache is 10.8, the proportion of those with nasal obstruction is 16.6, the proportion of those with Rhiorrhea is 11.7. Sore throat in approximately 26.0% of patients, dry throat in 16.1%, loss of smell in 31.8%, loss of taste in 34.5%, ear pain in 2.7%, dizziness in 2.2%, and hearing loss in 0.9% were the common complaints of the patients.
There are significant differences between the Patient Clinical Status variable in terms of Comorbidity Status, General Medication, Lopinavir/Ritonavir, Favipiravir, Fever Presence, Cough Presence, Cough Presence, Fatigue Presence, Dyspnea Presence, Smell Loss Presence, Dizziness Presence, and Hearing Loss Presence variables (Pearson’s Chi-Squared Test; p<0.05).